MARC

LEADER 00000cam a2200000 a 4500
001 SCIDIR_ocn956520504
003 OCoLC
005 20231120112127.0
006 m o d
007 cr |n|||||||||
008 160812s2016 enk ob 001 0 eng d
040 |a IDEBK  |b eng  |e pn  |c IDEBK  |d N$T  |d EBLCP  |d OPELS  |d OCLCF  |d N$T  |d OCLCQ  |d QCL  |d OCLCQ  |d U3W  |d D6H  |d YDX  |d OCLCO  |d MERER  |d OCLCQ  |d OCLCO  |d WYU  |d OCLCO  |d OCLCQ  |d OCLCA  |d OCLCQ  |d S2H  |d OCLCO  |d OCLCQ  |d OCLCO 
019 |a 961930699  |a 993591641  |a 1006322204  |a 1066430837  |a 1086096859 
020 |a 0128033134  |q (electronic bk.) 
020 |a 9780128033135  |q (electronic bk.) 
020 |z 9780128033128 
020 |z 0128033126 
035 |a (OCoLC)956520504  |z (OCoLC)961930699  |z (OCoLC)993591641  |z (OCoLC)1006322204  |z (OCoLC)1066430837  |z (OCoLC)1086096859 
050 4 |a RC667 
060 4 |a 2016 J-254 
060 4 |a WG 120 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
082 0 4 |a 616.1  |2 23 
245 0 0 |a Cardiovascular diseases :  |b genetic susceptibility, environmental factors and their interaction /  |c edited by Nikolaos Papageorgiou. 
260 |a London, United Kingdom :  |b Academic Press,  |c 2016. 
300 |a 1 online resource (254) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Print version record. 
505 0 |a Front Cover; Cardiovascular Diseases; Cardiovascular Diseases: Genetic Susceptibility, Environmental Factors and their Interaction; Copyright; Dedication; Contents; List of Contributors; Acknowledgments; 1 -- Summary ; 2 -- Atherosclerosis and Coronary Artery Disease: From Basics to Genetics ; INTRODUCTION; NORMAL ARTERY STRUCTURES; PATHOGENESIS OF ATHEROSCLEROSIS; INITIATION OF ATHEROMA; The Role of Endothelium; The Role of LDL Particles; The Role of Inflammation; Monocyte-Derived Macrophages; LDL and Inflammation; Atheroprotective Mechanisms and Inflammation; Retention of Macrophages. 
505 8 |a T LymphocytesTHE FORMATION OF ATHEROSCLEROTIC PLAQUE; Apoptosis and Efferocytosis of Macrophages; The Role of Vascular Smooth Muscle Cells; Neovascularization; CLINICAL IMPLICATIONS OF ATHEROSCLEROSIS; GENETICS OF CORONARY ARTERY DISEASE; ABO Blood Groups; Lipid-Associated Genes; Other Atherosclerosis-Related Genes; The Role of microRNAs; ATHEROSCLEROSIS: THERAPEUTIC OPTIONS; REFERENCES; 3 -- The Role of Genetics in Acute Coronary Syndrome ; INTRODUCTION; CLOPIDOGREL; Metabolism and Pharmacokinetics; Absorption and Role of P-glycoprotein; Hepatic Carboxylation and Oxidation. 
505 8 |a Effect of Genotypic PolymorphismsABCB1; CYP2C19; Nomenclature; CYP2C19*2 and Other Loss-of-Function Alleles; Pharmacokinetics/Pharmacodynamics; Clinical Trials and Meta-analyses; CYP2C19*17 Gain of Function Allele; Incidence of CYP2C19 Alleles in Specific Ethnic Groups; CYP3A4; CYP1A2; Paraoxonase 1; CYP4F2; Platelet Surface Receptors; P2Y12 Receptor; Platelet Endothelial Aggregation Receptor-1; Protease Activated Receptors; Nongenetic Factors; Clopidogrel and Proton Pump Inhibitors; PRASUGREL; Metabolism; Pharmacokinetics, Pharmacodynamics, and Clinical Trials; TICAGRELOR; Metabolism. 
505 8 |a Pharmacokinetics, Pharmacodynamics, and Clinical TrialsCompliance; Drug-Drug Interactions; GENOTYPING ASSAYS; COST-EFFECTIVENESS OF GENOTYPING; GENETIC POLYMORPHISMS RELATED TO ASPIRIN; FUTURE DIRECTIONS; Cilostazol and Role of Genetics; Statins and the Role of Genetics; SUMMARY: ROLE OF GENOTYPING IN ACUTE CORONARY SYNDROME; REFERENCES; 4 -- Global Epidemiology and Incidence of Cardiovascular Disease ; INTRODUCTION; GLOBAL BURDEN OF DISEASE: REPORTING METRICS; MEASURING THE GLOBAL BURDEN OF CARDIOVASCULAR DISEASE; Limitations of the Quality and Completeness of Data. 
505 8 |a CHANGES IN TOTAL DISEASE BURDEN VERSUS CVDGLOBAL CARDIOVASCULAR MORTALITY; Global CVD Mortality Rates by WHO Region; Global CVD Mortality Rates by WHO/World Bank Region; Age and Gender Global CVD Mortality Rates; GLOBAL CARDIOVASCULAR DALY; Global CVD Lost DALYs Within WHO Regions; Global CVD Lost DALYs by WHO/World Bank Region; Age and Gender Global CVD Loss of DALYs; RISK FACTORS FOR CVD GLOBALLY; Hypertension; Diabetes Mellitus; Tobacco; Dyslipidemia; Physical Activity; Alcohol Consumption; EPIDEMIOLOGICAL TRANSITION; AGING POPULATION; ETHNICITY; European; Chinese; South Asian; Hispanic. 
504 |a Includes bibliographical references and index. 
650 0 |a Cardiovascular system  |x Diseases. 
650 0 |a Cardiovascular system  |x Diseases  |x Genetic aspects. 
650 1 2 |a Cardiovascular Diseases  |x genetics  |0 (DNLM)D002318Q000235 
650 1 2 |a Cardiovascular Diseases  |x etiology  |0 (DNLM)D002318Q000209 
650 2 |a Cardiovascular Diseases  |0 (DNLM)D002318 
650 2 2 |a Genetic Predisposition to Disease  |0 (DNLM)D020022 
650 2 2 |a Environment  |0 (DNLM)D004777 
650 6 |a Appareil cardiovasculaire  |x Maladies.  |0 (CaQQLa)201-0057760 
650 6 |a Appareil cardiovasculaire  |0 (CaQQLa)201-0057760  |x Maladies  |0 (CaQQLa)201-0057760  |x Aspect g�en�etique.  |0 (CaQQLa)201-0377534 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Cardiovascular system  |x Diseases  |2 fast  |0 (OCoLC)fst00847181 
650 7 |a Cardiovascular system  |x Diseases  |x Genetic aspects  |2 fast  |0 (OCoLC)fst00847194 
700 1 |a Papageorgiou, Nikolaos. 
776 0 8 |i Print version:  |t Cardiovascular diseases.  |d London, United Kingdom : Academic Press, 2016  |z 9780128033128  |z 0128033126  |w (OCoLC)900032389 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780128033128  |z Texto completo